Infect Chemother.  2003 Aug;35(4):221-225.

Disseminated Aspergillosis following Allogeneic Hematopoietic Stem Cell Transplantation in an Acute Leukemic Patient who was Previously Treated for Invasive Aspergillosis

Affiliations
  • 1Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea. heechoi@ewha.ac.kr
  • 2Department of Internal Pathology, Ewha Womans University College of Medicine, Seoul, Korea.

Abstract

Invasive aspergillosis has been increasing as the number of severe immunocompromised hosts rises. Particularly, in allogeneic hematopoietic stem cell transplantation (HSCT) recipients, incidence of invasive aspergillosis ranges from 4 to 10%. Even with appropriate treatment, the prognosis of invasive aspergillosis in allogeneic HSCT recipients remains poor, showing high mortality rate. Herein, we report a case where invasive aspergillosis in a patient with acute myelogeneous leukemia progressed to disseminated aspergillosis after allogeneic HSCT. A 31-year-old woman with acute myelogenous leukemia had invasive aspergillosis after third reinduction chemotherapy. After administering amphotericin B, the patient underwent the wedge resection of lung, and HLA-matched allogeneic HSCT was then conducted. On day 14 of transplantation, the patient died of disseminated aspergillosis, including possible cerebritis and endocarditis despite the amphotericin B therapy.

Keyword

Aspergillosis; Leukemia; Stem cell transplantation

MeSH Terms

Adult
Amphotericin B
Aspergillosis*
Drug Therapy
Endocarditis
Female
Hematopoietic Stem Cell Transplantation*
Hematopoietic Stem Cells*
Humans
Immunocompromised Host
Incidence
Leukemia
Leukemia, Myeloid, Acute
Lung
Mortality
Prognosis
Stem Cell Transplantation
Amphotericin B
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr